Critical Reviews in Oncology/Hematology : Impact Factor & More
eISSN: 1879-0461pISSN: 1040-8428
Share this on:
Key Metrics
CiteScore 
9.7
Impact Factor
5 - 10
SJR
Q1Oncology
SNIP
1.75
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Critical Reviews in Oncology/Hematology
Critical Reviews in Oncology/Hematology Journal Specifications
| Overview | |
| Publisher | ELSEVIER SCIENCE INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1989 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Critical Reviews in Oncology/Hematology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Critical Reviews in Oncology/Hematology
Hybrid membrane nanosystems for cancer immunotherapy: Biomimetic design, immune activation, and translational potential.
- 1 Sep 2026
- Critical reviews in oncology/hematology
Single-cell RNA sequencing unveils CD8+ T cell heterogeneity in the diffuse large B-cell lymphoma microenvironment: A systematic review.
- 1 Aug 2026
- Critical reviews in oncology/hematology
Radiotherapy in primary central nervous system lymphoma: Evolution of its role and current position in combined treatment strategies.
- 1 Aug 2026
- Critical reviews in oncology/hematology
Context-dependent rewiring of the cGAS-STING pathway in cancer: Implications for immunotherapy and therapeutic resistance.
- 1 Aug 2026
- Critical reviews in oncology/hematology
Immunotherapeutic strategies in HPV-positive and HPV-negative recurrent/metastatic oropharyngeal squamous cell carcinoma: From PD-1 blockade to EGFR-directed bispecifics and therapeutic HPV vaccines.
- 1 Aug 2026
- Critical reviews in oncology/hematology
Emerging biomarkers for the early detection of high-grade serous tubo-ovarian cancer.
- 1 Aug 2026
- Critical reviews in oncology/hematology
Hybrid membrane nanosystems for cancer immunotherapy: Biomimetic design, immune activation, and translational potential.
- 1 Sep 2026
- Critical reviews in oncology/hematology
Single-cell RNA sequencing unveils CD8+ T cell heterogeneity in the diffuse large B-cell lymphoma microenvironment: A systematic review.
- 1 Aug 2026
- Critical reviews in oncology/hematology
Radiotherapy in primary central nervous system lymphoma: Evolution of its role and current position in combined treatment strategies.
- 1 Aug 2026
- Critical reviews in oncology/hematology
Context-dependent rewiring of the cGAS-STING pathway in cancer: Implications for immunotherapy and therapeutic resistance.
- 1 Aug 2026
- Critical reviews in oncology/hematology
Immunotherapeutic strategies in HPV-positive and HPV-negative recurrent/metastatic oropharyngeal squamous cell carcinoma: From PD-1 blockade to EGFR-directed bispecifics and therapeutic HPV vaccines.
- 1 Aug 2026
- Critical reviews in oncology/hematology
Emerging biomarkers for the early detection of high-grade serous tubo-ovarian cancer.
- 1 Aug 2026
- Critical reviews in oncology/hematology
FAQs on Critical Reviews in Oncology/Hematology
How long has Critical Reviews in Oncology/Hematology been actively publishing? 
What is the publishing frequency of Critical Reviews in Oncology/Hematology?
How many articles did Critical Reviews in Oncology/Hematology publish last year?
What is the eISSN & pISSN for Critical Reviews in Oncology/Hematology?
What is Citescore for Critical Reviews in Oncology/Hematology?
What is SNIP score for Critical Reviews in Oncology/Hematology?
What is the SJR for Critical Reviews in Oncology/Hematology?
Who is the publisher of Critical Reviews in Oncology/Hematology?
